Table 3 Details of the nine patients in whom the PMSCC method was used
Patient | Age (yr) | Sex | Lesion site | Length of resected specimen (cm) | Oral antithrombotic agent | Dialysis | Heparin replacement | Vonoprazan | Blood type |
|---|---|---|---|---|---|---|---|---|---|
1 | 78 | M | Lower | 4.3 | Aspirin | − | + | + | A |
2 | 85 | M | Lower | 4.3 | Nicorandil | + | − | + | B |
3 | 72 | M | Middle | 2.2 | Warfarin | − | − | + | A |
4 | 74 | M | Middle | 4.8 | DOAC | − | − | + | A |
5 | 66 | M | Upper | 4.1 | DOAC | − | − | + | A |
6 | 66 | M | Middle | 7.0 | − | + | − | + | O |
7 | 70 | M | Middle | 1.9 | Warfarin | − | − | + | O |
8 | 74 | M | Middle | 4.0 | Warfarin | − | − | + | B |
9 | 61 | M | Middle | 3.1 | DOAC + others | − | − | + | B |